Key result
Optimal prevention of recurrent coronary ischaemia and the use of an implantable cardioverter-defibrillator (ICD) in high-risk patients are the most effective ways to reduce sudden cardiac death risk.
This review highlights the importance of optimal prevention of recurrent coronary ischaemia and ICD implantation for reducing sudden cardiac death risk in patients with ischaemic cardiomyopathy.
Sudden cardiac death (SCD) is an important cause of mortality. In this article, we review the definition, impact and underlying aetiology of SCD. Ventricular tachyarrhythmia accounts for the majority of SCDs and can be caused by various underlying heart diseases, the most frequent being ischaemic cardiomyopathy. The most effective ways to reduce the risk of SCD in ischaemic cardiomyopathy are the optimal prevention of recurrent coronary ischaemia and the use of an implantable cardioverter-defibrillator (ICD) in high-risk patients. We discuss current patient selection for ICD implantation and focus on the need for, and possibilities to improve, SCD risk stratification.
No takes yet. Share an insight, caveat, or question.
Floré et al. (2012) conducted a review in Ischaemic cardiomyopathy. Implantable cardioverter-defibrillator (ICD) was evaluated. Optimal prevention of recurrent coronary ischaemia and the use of an implantable cardioverter-defibrillator (ICD) in high-risk patients are the most effective ways to reduce sudden cardiac death risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: